Jason K Gurney1, James Stanley2, Steve York3, Dieter Rosenbaum4, Diana Sarfati2. 1. Cancer and Chronic Conditions (C3) Research Group, Department of Public Health, University of Otago, 23a Mein St, Newtown, Wellington, New Zealand. jason.gurney@otago.ac.nz. 2. Cancer and Chronic Conditions (C3) Research Group, Department of Public Health, University of Otago, 23a Mein St, Newtown, Wellington, New Zealand. 3. High Risk Foot Clinic, Northland District Health Board, Whangarei, New Zealand. 4. Movement Analysis Lab, University Hospital Muenster, Muenster, Germany.
Abstract
AIMS/HYPOTHESIS: Lower limb amputation is a serious complication of diabetes mellitus. Understanding how amputation risk differs by population subgroups is crucial in terms of directing preventive strategies. In this study, we describe those factors that impact amputation risk in the entire prevalent diabetic population of New Zealand. METHODS: A national prevalent cohort of 217,207 individuals with diabetes in 2010 were followed up until the end of 2013 for lower limb amputations, and 2014 for mortality. Inpatient hospitalisation data were used to define lower limb amputation using ICD-10 codes. Cox proportional hazards models were used to describe relative hazard of amputation over the follow-up period. RESULTS: A total of 784 individuals (3.6 cases/1000 individuals) underwent a major (above-ankle) lower limb amputation during follow-up, while 1217 (5.6/1000) underwent a minor (below ankle) amputation. The risk of major and minor amputation was 39% and 77% greater for men than women, respectively (adjusted HR: major amputation 1.39, 95% CI 1.20, 1.61; minor amputation 1.77, 95% CI 1.56, 2.00). Indigenous Māori were at 65% greater risk of above-knee amputation compared with the European/Other diabetic population (HR 1.65, 95% CI 1.37, 1.97). Amputation risk increased with increasing comorbidity burden, and peripheral vascular disease conferred the greatest independent risk of all comorbid conditions. Prior minor amputation increased the risk of subsequent major amputation by tenfold (HR 10.04, 95% CI 7.83, 12.87), and increased the risk of another minor amputation by 20-fold (HR 21.39, 95% CI 17.89, 25.57). Death was common among the total cohort, but particularly among those who underwent amputation, with more than half of those who underwent a major amputation dying within 3 years of their procedure (57%). CONCLUSIONS/ INTERPRETATION: Using a large, well-defined, national prevalent cohort of people with diabetes, we found that being male, indigenous Māori, living in deprivation, having a high comorbidity burden and/or having a previous amputation were strongly associated with subsequent risk of lower limb amputation. The use of this prevalent cohort strengthens the value of our estimates in terms of applicability to the general population, and highlights the subgroups at greatest risk of lower limb amputation.
AIMS/HYPOTHESIS: Lower limb amputation is a serious complication of diabetes mellitus. Understanding how amputation risk differs by population subgroups is crucial in terms of directing preventive strategies. In this study, we describe those factors that impact amputation risk in the entire prevalent diabetic population of New Zealand. METHODS: A national prevalent cohort of 217,207 individuals with diabetes in 2010 were followed up until the end of 2013 for lower limb amputations, and 2014 for mortality. Inpatient hospitalisation data were used to define lower limb amputation using ICD-10 codes. Cox proportional hazards models were used to describe relative hazard of amputation over the follow-up period. RESULTS: A total of 784 individuals (3.6 cases/1000 individuals) underwent a major (above-ankle) lower limb amputation during follow-up, while 1217 (5.6/1000) underwent a minor (below ankle) amputation. The risk of major and minor amputation was 39% and 77% greater for men than women, respectively (adjusted HR: major amputation 1.39, 95% CI 1.20, 1.61; minor amputation 1.77, 95% CI 1.56, 2.00). Indigenous Māori were at 65% greater risk of above-knee amputation compared with the European/Other diabetic population (HR 1.65, 95% CI 1.37, 1.97). Amputation risk increased with increasing comorbidity burden, and peripheral vascular disease conferred the greatest independent risk of all comorbid conditions. Prior minor amputation increased the risk of subsequent major amputation by tenfold (HR 10.04, 95% CI 7.83, 12.87), and increased the risk of another minor amputation by 20-fold (HR 21.39, 95% CI 17.89, 25.57). Death was common among the total cohort, but particularly among those who underwent amputation, with more than half of those who underwent a major amputation dying within 3 years of their procedure (57%). CONCLUSIONS/ INTERPRETATION: Using a large, well-defined, national prevalent cohort of people with diabetes, we found that being male, indigenous Māori, living in deprivation, having a high comorbidity burden and/or having a previous amputation were strongly associated with subsequent risk of lower limb amputation. The use of this prevalent cohort strengthens the value of our estimates in terms of applicability to the general population, and highlights the subgroups at greatest risk of lower limb amputation.
Authors: Chin-Lin Tseng; Mangala Rajan; Donald R Miller; Gerald Hawley; Stephen Crystal; Minge Xie; Anjali Tiwari; Monika Safford; Leonard Pogach Journal: Med Care Date: 2005-01 Impact factor: 2.983
Authors: Charlotte P Stenqvist; Camilla T Nielsen; George M Napolitano; Bo M Larsen; Mitchell J Flies; Ditte C Brander; Elsebeth Lynge; Per Pallesen Journal: Int Wound J Date: 2019-08-12 Impact factor: 3.315
Authors: Martin C Berli; Zoran Rancic; Madlaina Schöni; Tobias Götschi; Pascal Schenk; Method Kabelitz; Thomas Böni; Felix W A Waibel Journal: Arch Orthop Trauma Surg Date: 2021-08-09 Impact factor: 3.067
Authors: Thenmalar Vadiveloo; William Jeffcoate; Peter T Donnan; Helen C Colhoun; Stuart McGurnaghan; Sarah Wild; Rory McCrimmon; Graham P Leese Journal: Diabetologia Date: 2018-08-31 Impact factor: 10.122
Authors: Silvia Cascini; Nera Agabiti; Marina Davoli; Luigi Uccioli; Marco Meloni; Laura Giurato; Claudia Marino; Anna Maria Bargagli Journal: BMJ Open Diabetes Res Care Date: 2020-07
Authors: Ana López-de-Andrés; Rodrigo Jiménez-García; Maria D Esteban-Vasallo; Valentin Hernández-Barrera; Javier Aragon-Sánchez; Isabel Jiménez-Trujillo; Javier de Miguel-Diez; Maria A Palomar-Gallego; Martin Romero-Maroto; Napoleón Perez-Farinos Journal: J Clin Med Date: 2019-10-02 Impact factor: 4.241
Authors: Sadaf Kamil; Thomas S G Sehested; Nicholas Carlson; Kim Houlind; Jens F Lassen; Casper N Bang; Helena Dominguez; Christian T Pedersen; Gunnar H Gislason Journal: BMC Cardiovasc Disord Date: 2019-10-24 Impact factor: 2.298